2024-518988-35-00已完成4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatment of uncomplicated lower urinary tract infections.
Sciencepharma Sp. z o.o.1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2025年3月31日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 34
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trials Team
Scientific
Sciencepharma Sp. z o.o.
研究点 (1)
Loading locations...
相似试验
招募中
4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment of schizophrenia in adult patients.2025-521400-21-00Adamed Pharma S.A.54
已完成
1 期
Pivotal in vivo bioequivalence study comparing two formulations of methylprednisolone aceponate fatty ointment applied to the skin in healthy male and female volunteers.ACTRN12620000160932Zenith Technology Corporation Limited95
已完成
1 期
Pivotal in vivo bioequivalence study comparing two formulations of betamethsone ointment applied to the skin in healthy male and female volunteers.Betamethasone ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.Skin - Dermatological conditionsACTRN12624000107527Zenith Technology Corporation Limited90
已完成
1 期
Pivotal in vivo bioequivalence study comparing two formulations of 21-acetoxyl group-11 beta-hydroxy-6 Alpha-Methyls-17-propiono Oxy-1,4-pregnen diethylene-3,20-diketone fatty ointment applied to the skin in healthy male and female volunteers.21-acetoxyl group-11 beta-hydroxy-6 Alpha-Methyls-17-propiono Oxy-1,4-pregnen diethylene-3,20-diketone fatty ointment is indicated for the short term treatment of the milder form of eczema, dermatitis and other steroid responsive skin conditionsSkin - Dermatological conditionsACTRN12623000571673Zenith Technology Corporation Limited90
已完成
1 期
Pivotal in vivo bioequivalence study comparing two formulations of 9-fluoro-11ß-hydroxy- 16ß-methyl-3,20-dioxopregna- 1,4-diene-17,21-diyl dipropanoate cream applied to the skin in healthy male and female volunteers.ACTRN12623001003662Zenith Technology Corporation Limited90